Dr. Mark William Sheldon, MD

Dr. Sheldon practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Sheldon's NPI, 1568425726, was assigned on April 10, 2006. Dr. Sheldon holds New Mexico license 2001-307.

Dr. Sheldon's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Sheldon's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. The medical group on file is UNM Medical Group, Inc.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sheldon practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Sheldon's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Sheldon is licensed in New Mexico.

CMS data shows 487 Medicare services from Dr. Sheldon across 11 procedure codes in 2024, for 365 Medicare patients. Medicare paid $17,683 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 365 Medicare patients who saw Dr. Sheldon in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sheldon's median patient age at 73, with 42% women.

In 2024, Dr. Sheldon wrote 1,247 Medicare Part D claims for 169 patients. 85% of them were for generic drugs. CMS names the drug for 1,105 of them, across 20 drugs with 11 or more claims each, at $151,326 in total drug cost. In 2023, CMS named 1,125 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Sheldon for performance year 2024, reported as part of a group. Dr. Sheldon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Sheldon, published from 2007 to 2023. 2017 was the busiest year, with 2. The most frequent topics are Percutaneous Coronary Intervention, Coronary Aneurysm and Coronary Angiography. Dr. Sheldon has published most often in BMJ Case Rep. Dr. Sheldon's most frequent co-authors are James Blankenship, MD, Bina Aftab Ahmed, MD and Shozab Ahmed.

Dmand AI links Dr. Sheldon to 1 clinical trial. Conditions studied include Myocardial Infarction and Infarction.

CMS Open Payments shows 91 general payments to Dr. Sheldon from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Boston Scientific Corporation paid the most, $1,152.